2007-04-20
Håkan Åström appointed as new chairman of the board of Affibody
Affibody Holding AB, a biotech company that has developed a late-stage pipeline of oncology products for molecular imaging and targeted therapy, announces that the Annual General Meeting on 20 April 2007 appointed Håkan Åström as new chairman of the board and Ursula Ney as a new board member.
The board of directors of Affibody Holding AB comprises, besides Håkan Åström and Ursula Ney, also Karl Swartling, Björn Odlander and Mathias Uhlén.